events rule
3rd Microbiome Forum: USA
Thursday, September 10, 2015

Joseph A. Sliman, MD, MPH, Senior Vice President, Clinical & Regulatory Affairs, to present at the forum in San Diego, CA.
Presentation Topic: "Protecting the Gut Microbiome"
Webcasting is not available at this forum.

FBR & Co. 2nd Annual Healthcare Conference
Wednesday, September 9, 2015

Jeffrey Riley, CEO, was invited to participate in FBR's One-on-One Healthcare Conference in Boston, MA.

The Peggy Lillis Foundation - C. diff Advocates Summit
Friday, August 21, 2015 - Saturday, August 22, 2015

Klaus Gottlieb, MD, FACG, Vice President, Clinical & Regulatory Affairs, will present at the summit during "The Future of Prevention & Treatment" session on Friday, August 21st.

Second Quarter 2015 Investor Conference Call
Monday, August 10, 2015
8:30am EDT

The dial-in information for the call is as follows: U.S. toll free: 1-888-347-5280 and International: +1 412-902-4280

Participants are asked to dial in 15 minutes before the start of the call to register. The call will also be webcast over the Internet at https://www.webcaster4.com/Webcast/Page/1096/9809. An archive of the call will be available for approximately 90 days at the same URL, https://www.webcaster4.com/Webcast/Page/1096/9809, beginning approximately one hour after the call’s conclusion.

Biochemical and Molecular Engineering XIX
Sunday, July 12, 2015 - Thursday, July 16, 2015

Title: SYN-004, a Novel, Clinical-Stage Oral Beta-Lactamase Therapy to Protect the Microbiome from Antibiotic-Mediated Damage

Authors: Sheila Connelly1, J. Andrew Bristol1, Steven Hubert1, John Kokai-Kun1, Olivia Coughlin1, Amy Sloan1, Heidi Whalen1, Tracey Roberts1, Michael Schlosser1, Pertti Koski1, Todd Parsley2, Giovanni Widmer3, Jean Mukherjee3; Kevin Huynh3, Saul Tzipori3, Joseph Sliman1, Michael Kaleko1. 1Synthetic Biologics, Inc., Rockville, MD; 2SynPhaGen, LLC, Gaithersburg, MD, 3Tufts Cummings School of Veterinary Medicine, North Grafton, MA.
Click to view presentation.

International Conference on the Evolution and Transfer of Antibiotic Resistance (ICETAR)
Wednesday, June 24, 2015 - Friday, June 26, 2015

An oral presentation was presented at ICETAR 2015, as follows:

Title:  Novel broad-spectrum beta-lactamase therapy to protect the gut microbiome from antibiotics

Authors:  Sheila Connelly1, Todd Parsley2, Pertti Koski1, Michael Kaleko1, 1Synthetic Biologics, Inc., 2SynPhaGen, LLC.

Click to view presentation.

SYN Microbiome Analyst & Investor Meeting
Wednesday, June 3, 2015
9:00am - 11:30am EDT

Grand Hyatt New York Hotel - Manhattan Ballroom

The archived webcast is available at: https://tallen.webcasts.com/starthere.jsp?ei=1066312.

To access the slide deck from SYN's Microbiome Analyst & Investor Meeting, click here.

 

American Society of Microbiology 2015
Saturday, May 30, 2015 - Tuesday, June 2, 2015

Two posters were presented at ASM 2015, as follows:

Title: Clinical Evaluation of SYN-004, an Oral Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
Authors: J. Sliman, J. A. Bristol, S. Hubert, O. Coughlin, J. Kokai-Kun, A. Sloan, H. Whalen, T. Roberts, M. Schlosser, S. Connelly, P. Koski, M. Kaleko; Synthetic Biologics, Inc., Rockville, MD
Click to view abstract. Click to view poster.

Title: Development of Therapeutic Agents that Protect the Colonic Microflora from Beta-Lactam Antibiotics for the Prevention of Clostridium difficile Infection
Authors: S. Connelly1, T. Parsley2, P. Koski1, M. Kaleko1; 1Synthetic Biologics, Inc., Rockville, MD, 2SynPhaGen, LLC, Rockville, MD
Click to view abstract. Click to view poster.

Digestive Disease Week® 2015
Saturday, May 16, 2015 - Tuesday, May 19, 2015

Two posters were presented at DDW 2015, as follows:

Title: SYN-004, a Clinical Stage Oral Beta-Lactamase Therapy, Protects the Intestinal Microflora from Antibiotic-Mediated Damage in Humanized Pigs.
Authors: Sheila Connelly, Giovanni Widmer, Jean Mukherjee, Kevin Huynh, J. Andrew Bristol, Steven Hubert, Joseph Sliman, Saul Tzipori, Michael Kaleko.
Click to view abstract. Click to view poster.

Title: Lovastatin improves stool form in Methanobrevibacter smithii colonized rats with constipation.
Authors: Walter Morales, Emily Marsh, Allen Yu, Zachary Marsh, Stacy Weitsman, Gillian M. Barlow, Ali Rezaie, Christopher Chang, Vince Wacher, Mark Pimentel.
Click to view abstract. Click to view poster.

2015 Annual Meeting of Stockholders
Friday, May 15, 2015
9:00am EDT

The 2015 Annual Meeting of Stockholders of Synthetic Biologics, Inc., a Nevada corporation, will be held on May 15, 2015 at 9:00 a.m. (Eastern time), at the New York City office of Gracin & Marlow, LLP, Chrysler Building, 405 Lexington Avenue, 26 th  Floor, New York, New York, 10174.

1st Annual Translational Microbiome Conference
Thursday, May 14, 2015
8:50am - 9:20am EDT

Jeffrey Riley, CEO, to present at this conference in Boston, MA.
Presentation Topic: "Pioneering Approaches to Protect the Microbiome."
Webcasting is not available at this conference; please click here to view slide deck.
For more information about the conference, please visit http://microbiomeconference.com/.

 

First Quarter 2015 Investor Conference Call
Monday, May 11, 2015
4:30pm EDT

The dial-in information for the call is as follows:
U.S. toll free: 1-888-347-5280
Canada toll free: 1-855-669-9657
International: +1 412-902-4280

Participants are asked to dial in 15 minutes before the start of the call to register. Registered callers may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=102272. An archive of the call will be available for approximately 90 days at the same URL, http://www.videonewswire.com/event.asp?id=102272, beginning approximately one hour after the call’s conclusion.

2nd Microbiome R&D and Business Collaboration Forum: Europe
Thursday, May 7, 2015

Joseph A. Sliman, MD, MPH, Senior Vice President, Clinical & Regulatory Affairs, to present at the forum in London, UK.
Presentation Topic: "Pioneering Approaches to Protect the Microbiome"
Webcasting is not available at this forum.

ECCMID 2015 (European Congress of Clinical Microbiology and Infectious Diseases)
Saturday, April 25, 2015 - Tuesday, April 28, 2015

Two posters were presented under the Respiratory Infections category at ECCMID 2015 in Copenhagen, Denmark on 50 ePoster stations, as follows:

Title: Antibody Cocktail Effectively Treats Pertussis in a Baboon Disease Model
Authors: J. A. Maynard, A. Nguyen, E. Wagner, J. Laber, L. Goodfield, W. Smallridge, E. T. Harvill, R. F. Wolf, J. C. Papin, S. Connelly, J. A. Bristol, M. Kaleko
Click to view abstract. Click to view poster.

Title: Spontaneous Identification of Bordetella bronchiseptica in a Baboon Colony: Potential Ramifications for Bordetella pertussis Modeling
Authors: M. Kaleko, A. Nguyen, E. Wagner, R. F. Wolf, J. C. Papin, S.Connelly, J. A. Bristol, J. A. Maynard
Click to view abstract. Click to view poster.

C. diff Spores and More on C. diff Radio
Tuesday, March 31, 2015
2:00pm EDT

Lewis Barrett, BS, MBA, Senior Vice President, Commercial Strategy and Joseph A. Sliman, MD, MPH, Senior Vice President, Clinical & Regulatory Affairs will discuss the novel point-of-care preventive approach of SYN-004, the Company's lead pathogen-specific product candidate for the prevention of C. difficile infection. To listen to the C. diff Spores and More radio episode podcast replay via the internet click here.

Episode hosted by the C. diff Foundation, www.cdifffoundation.org

2014 Year End Investor Conference Call
Monday, March 16, 2015
8:30am EDT

Synthetic Biologics will hold an investor conference call on Monday, March 16th, at 8:30 a.m. EDT. Interested parties should call 1-888-347-5280 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-902-4280 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=101639. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=101639, for 30 days after the call.

27th Annual ROTH Conference
Tuesday, March 10, 2015
1:00pm PDT

Jeffrey Riley, Synthetic Biologics' CEO, is scheduled to present on Tuesday, March 10, 2015 at 1:00 p.m. (Pacific Time). A live webcast of Synthetic Biologics' presentation can be accessed by logging onto the web at http://wsw.com/webcast/roth29/syn. After the presentation, a replay will be archived and accessible for 30 days at the same website.

SYN's CEO Panelist on "Trust Your Gut" - Therapeutic Opportunities from the Microbiome Panel
Tuesday, February 10, 2015
8:00am - 8:55am EST

Jeffrey Riley, CEO, was invited to participate on the following panel at the BIO CEO & Investor Conference 2015:

“Trust Your Gut”—Therapeutic Opportunities from the Microbiome

The panel will review emerging data that the bacterial colonies of the digestive system influence far more non-digestive systems than previously believed, while creating natural antibiotics and other compounds that may be an underleveraged source for efficient drug discovery.

Panel Moderator: Mark Breidenbach, PhD, Equity Research Group, H.C. Wainwright & Co.

BIO CEO & Investor Conference 2015
Monday, February 9, 2015
1:30pm EST

Synthetic Biologics WON the BIO CEO & Investor Conference's "Buzz of BIO" contest in the Most Distinguished Public Company category!

Jeffrey Riley, CEO, is scheduled to present at the BIO CEO & Investor Conference on Monday, February 9, 2015, at 1:30 p.m. (ET) at the Waldorf Astoria in New York.

A live webcast of Synthetic Biologics' presentation may be accessed by logging onto the internet at http://www.veracast.com/webcasts/bio/ceoinvestor2015/42118168151.cfm. After the presentation, a replay will be archived and accessible for 90 days at the same website.

Biotech Showcase 2015 Conference
Tuesday, January 13, 2015
2:00pm PST

Jeffrey Riley, CEO, will present at the Biotech Showcase 2015 Conference at 2:00 p.m. (PT) on Tuesday, January 13, 2015 in the Mission II Room at the Parc 55 Wyndham San Francisco-Union Square Hotel.

A live webcast of Synthetic Biologics' presentation may be accessed by logging onto the internet at http://edge.media-server.com/m/p/pqjict2k. After the presentation, a replay will be archived and accessible for 90 days at the same website.

THANK YOU! Synthetic Biologics WON the Buzz of BIO Contest!
Monday, December 8, 2014

Thank you to everyone for participating in the Buzz of BIO Contest, recognizing the most innovative companies at the 2015 BIO CEO & Investor Conference! On Monday, December 8, 2015, we were informed that Synthetic Biologics WON this year’s contest in the Most Distinguished Public Company category. For more information, visit this Buss of BIO webpage: https://www.bio.org/ceobuzzofbio.

As the winner of this category, Synthetic Biologics will receive one (1) complimentary registration to the 2015 BIO CEO & Investor Conference, as well as a complimentary “public company” presentation spot.

Thank you for supporting Synthetic Biologics!

Buzz of BIO Contest - Vote for Synthetic Biologics!
Monday, December 1, 2014 - Friday, December 5, 2014

Synthetic Biologics, Inc. is pleased to be one of ten biotechs nominated in the category of “Most Distinguished Public Company” as part of the Buzz of BIO Contest, in association with the 17th Annual BIO CEO & Investor Conference, which will feature leading private and emerging public companies on February 9-10, 2015, at the Waldorf Astoria in New York, NY.

Please vote and spread the word about Synthetic Biologics’ participation!

It's easy. Just visit http://www.bio.org/ceobuzzofbiovote starting Monday, December 1st, and vote for Synthetic Biologics under the “Most Distinguished Public Company” category.

Tell your friends and colleagues. Share your support on your social media (or link to ours). It takes mere seconds to bookmark the link, and you can vote once a day through December 5th at 5:00pm ET.

Winners will be announced the week of December 8, 2014.

Thank you!

Third Quarter 2014 Investor Conference Call
Friday, November 14, 2014
8:30am EST

Synthetic Biologics will hold an investor conference call on Friday, November 14th, at 8:30 a.m. EST. Interested parties should call 1-888-347-5280 (U.S. toll free), 1-855-669-9657 (Canada toll free), or +1 412-902-4280 (International), fifteen minutes before the start of the call to register. Registered callers on the toll free line may ask to be placed in the queue for the Question & Answer Session. The call will also be webcast over the Internet at http://www.videonewswire.com/event.asp?id=100975. If you are unable to participate during the live conference call, the webcast will be available for replay at the same URL, http://www.videonewswire.com/event.asp?id=100975, for 30 days after the call.

SYN's Irritable Bowel Syndrome (IBS) Investor Day
Tuesday, September 16, 2014
9:00am - 11:00am EDT

Synthetic Biologics' CEO, Jeffery Riley, will provide an overview of the anticipated clinical and regulatory pathway for SYN-010 to reduce the impact of methane producing organisms on C-IBS, including plans to file an Investigational New Drug (IND) application and initiate a Phase II dose-discovery and proof-of-mechanism clinical study in the second half of 2014. Keynote speaker, Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center and Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board, will discuss his groundbreaking work that led to the discovery of SYN-010, including the association between the overproduction of methane gas by microorganisms in the gut and conditions such as C-IBS, as well as further detail for SYN-010 itself.

Interested parties may log in to the live webcast and for replay after the event over the Internet at SYN IBS Investor Day Webcast.